Metropolis Healthcare
BSE 542650 · ISIN INE112L01020
4 stories, newest first.
- Metropolis Q2 business update showed 15% revenue growth driven by patient and test volume growth, with improved EBIT margins
- Metropolis Healthcare's business update showed ~15% revenue growth driven by volume growth and improved realization
- Metropolis Healthcare's revenue grew 15% with better margins
- Q2FY27 business update: revenue grew about 15% Y-o-Y; EBITDA margins improve both Y-o-Y and Q-o-Q
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.